D
Inhibikase Therapeutics, Inc. IKT
$2.37 $0.010.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -19.57M -18.38M -19.20M -19.03M -19.13M
Total Depreciation and Amortization 26.40K 26.40K 179.00K 177.40K 175.80K
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 368.60K 367.70K 461.80K 531.70K 474.70K
Change in Net Operating Assets 1.93M 1.52M 2.58M 234.70K 280.40K
Cash from Operations -17.24M -16.47M -15.98M -18.09M -18.20M
Capital Expenditure 0.00 0.00 -14.20K -14.20K -14.20K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -358.10K 14.18M 14.20M 11.67M 18.75M
Cash from Investing -358.10K 14.18M 14.18M 11.66M 18.74M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- 0.00
Issuance of Common Stock 3.79M 3.61M 398.20K 8.58M 8.58M
Repurchase of Common Stock -- -- -36.00K -36.00K -36.00K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -138.60K -138.60K -169.20K -138.60K --
Cash from Financing 3.66M 3.47M 193.00K 8.41M 8.54M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -13.95M 1.18M -1.60M 1.98M 9.08M
Weiss Ratings